Bio-Rad Laboratories, Inc. (BIO.B) vs Insulet Corporation (PODD)
Bio-Rad Laboratories, Inc. and Insulet Corporation are both Medical Devices companies. Bio-Rad Laboratories, Inc. and Insulet Corporation are of similar size ($10.3B and $9.6B). Insulet Corporation trades at the lower P/E: 25.4× against 43.8×. Insulet Corporation grew revenue faster over the last twelve months: 29.4% against 1.37%. Insulet Corporation has the higher net margin (12.3% vs 8.59%) and the higher return on invested capital (17.6% vs 0.49%). Across the 22 metrics below, Insulet Corporation leads on 14 and Bio-Rad Laboratories, Inc. on 8.
Valuation
Profitability
| Metric | BIO.B | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 71.07% | 56.01% |
| Operating margin | 2.05% | 16.89% | (15.03%) |
| Net margin | 8.59% | 12.29% | (20.40%) |
| Free cash flow margin | 13.64% | 8.70% | (7.24%) |
| Return on equity | 3.11% | 26.02% | (15.32%) |
| Return on assets | 2.17% | 11.31% | (19.72%) |
| Return on invested capital | 0.49% | 17.56% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack